clofibric acid has been researched along with Ascites in 1 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
Ascites: Accumulation or retention of free fluid within the peritoneal cavity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yokoyama, Y | 1 |
| Xin, B | 1 |
| Shigeto, T | 1 |
| Umemoto, M | 1 |
| Kasai-Sakamoto, A | 1 |
| Futagami, M | 1 |
| Tsuchida, S | 1 |
| Al-Mulla, F | 1 |
| Mizunuma, H | 1 |
1 other study available for clofibric acid and Ascites
| Article | Year |
|---|---|
Clofibric acid, a peroxisome proliferator-activated receptor alpha ligand, inhibits growth of human ovarian cancer.
Topics: Alcohol Oxidoreductases; Animals; Anticholesteremic Agents; Apoptosis; Ascites; Cell Line, Tumor; Ce | 2007 |